Regional and country-level analysis and forecasts of the Asia Pacific Apheresis Market, providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions those are still untapped
- Advertising -
According to the report “Asia Pacific Apheresis Market By Product (Devices And Disposables), Procedure (Donor, Therapeutic, Photopheresis), Application (Renal Diseases, Neurology, Cancer, Hematology, Autoimmune Diseases And Cardiovascular Diseases), Technology (Centrifuge And Membrane Separation), End User (Private Blood Collection Centres, Public Blood Collection Centres And Hospitals) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)” published by Market Data Forecast, The Asia Pacific Apheresis Market was worth USD 0.24 billion in 2016 and estimated to be growing at a CAGR of 12.58%, to reach USD 0.43 billion by 2021.
Browse details of 155 pages of research report on Asia Pacific Apheresis Market @ www.marketdataforecast.com/market-…esis-market-3086/
Apheresis is a medical procedure that involves removing whole blood from a donor or patient and separating the blood into individual components so that one particular component can be removed. The remaining blood components then are re-introduced back into the bloodstream of the patient or donor.
Presence of high unmet needs and rapidly increasing demand for platelets in the emerging Asia Pacific region is expected to serve this industry as future growth opportunities.
- Advertising -
As per the reports published by of the National Centre for Biotechnology Information, chronic renal diseases have a prevalence of 8% to 16 worldwide.
Rise in the number of accidents leading to demand for blood components, increasing incidences of chronic diseases and development of new apheresis techniques are some of the factors enhancing the market growth. Risk of blood getting infected, lack of skilled personnel to carry out the procedure and unavailability of both donor & specific blood group are some of the factors hindering the growth of the Asia Pacific Apheresis Market.
Avail Sample Market Brochure of the report for more information @ www.marketdataforecast.com/market-…86/request-sample
The Asia Pacific Apheresis Market is segmented into Product, Procedure, Application, Technology and End user. On the basis of product, the market is segmented into Apheresis devices and disposables.
Based on procedure, the market is segmented into donor/automated apheresis and therapeutic apheresis. The Application segment includes Renal Diseases, Neurology, Cancer, Hematology, Autoimmune Diseases and Cardiovascular Diseases.
On the basis of technology, the market is segmented into Centrifuge and Membrane Separation. Centrifuge segment include Intermittent Flow and Continuous Flow.
Based on End user, the market includes Private Blood Collection Centres, Public Blood Collection Centres and Hospitals.
The Asia Pacific Apheresis Market is geographically segmented into China, India, Japan, South Korea, and Australia. Asia Pacific is one of the most lucrative markets for the growth of Apheresis market and is projected to grow the highest during the forecast period.
Factors such as growing prevalence of blood disorders requiring plasma and platelet transfusion, growing demographics and emerging economies in countries such as India and China are anticipated to lead the growth of the market in this region. The Asia Pacific region has a global share of 16% and has a CAGR of 12.58%.
The key players in this Asia Pacific Apheresis Market are:
- Asahi Kasei Medical Co., Ltd.
- Haemonetics Corporation
- Terumo BCT, Inc.
- Fresenius Medical Care
- Kawasumi Laboratories Inc.
- Cerus Corporation
- HemaCare Corporation
- Kaneka Corporation
- B. Braun Melsungen AG
- Nikkiso Co., Ltd.
- Therakos, Inc.
- Medica S.p.A.
Make an Inquiry @ www.marketdataforecast.com/market-…rket-3086/inquire
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: